Acadia Pharmaceuticals buy StockNews.com
Start price
11.01.26
/
50%
€23.07
Target price
11.01.27
-
Performance (%)
-1.47%
Price
13.01.26
€22.73
Summary
This prediction is currently active. With a performance of -1.47%, the BUY prediction by StockNews_com is trending in the wrong direction. This prediction currently runs until 11.01.27. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Acadia Pharmaceuticals | -1.47% |
| iShares Core DAX® | 1.644% |
| iShares Nasdaq 100 | 0.747% |
| iShares Nikkei 225® | 2.442% |
| iShares S&P 500 | 0.618% |
Comments by StockNews_com for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals (NASDAQ:ACAD) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Ratings data for ACAD provided by MarketBeat
Stopped prediction by StockNews_com for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€14.60
14.09.24
14.09.24
-
14.09.25
14.09.25
36.96%
15.09.25
15.09.25
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€17.09
03.08.24
03.08.24
-
03.08.25
03.08.25
18.53%
04.08.25
04.08.25

